Generic omeprazole delayed-release capsules: In vitro performance evaluations

Drug Development and Industrial Pharmacy

Volumn 35, Issue 8, 2009, Pages 917-921

  Moore, Terry ^a   Smith, Anjanette ^a   Ye, Wei ^a   Toler, Duckhee Y ^a   Westenberger, Benjamin J ^a   Lionberger, Robert ^a   Raw, Andre ^a   Yu, Lawrence ^a   Buhse, Lucinda F ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Delayed release capsules; Dissolution; Generics; Omeprazole; Stability

Indexed keywords

GENERIC DRUG; OMEPRAZOLE; PRISOLEC; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DELAYED DRUG RELEASE; DRUG CAPSULE; DRUG MARKETING; DRUG SOLUBILITY; DRUG STABILITY; GASTROINTESTINAL TRACT; PH; SIMULATION;

ANTI-ULCER AGENTS; CAPSULES; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG APPROVAL; DRUGS, GENERIC; OMEPRAZOLE; PHARMACOPOEIAS AS TOPIC; SOLUBILITY; THERAPEUTIC EQUIVALENCY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 70350218630     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802698802     Document Type: Article

References (3)

1. Farinha A, Bica A, Martins JM, Pais JP. (2000). Dissolution of omeprazole from delayed-release solid oral dosage forms. Drug Dev Ind Pharm, 26:785-790
2. Robb-Nicholson C. (2007). By the way, doctor: Are generic and brand-name drugs really the same? Harv Womens Health Watch, 14(5):8.
3. Udd M, Toyry J, Miettinen P, Vanninen E, Mustonen H, Julkunen R. (2005). The effect of regular and high doses of omeprazole on the intragastric acidity in patients with bleeding peptic ulcer treated endoscopically: A clinical trial with continuous intragastic pH monitoring. Eur J Gastroenterol Hepatol, 17:1351-1356